as on September 17, 2025 at 10:40 pm IST
Day's Low
Day's High
5.65%
Downside
2.42%
Upside
52 Week's Low
52 Week's High
76.28%
Downside
356.14%
Upside
Check Tonix Pharmaceuticals Holding Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$237.7M
EPS (TTM)
-10.3
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0.01
Industry PE ratio
-3.9281873111782475
P/B Ratio
0.0107
PEG Ratio
0EBITDA
-79.9M
Revenue (TTM)
9.8M
Profit Margin
0.00%
Return On Equity TTM
-77.51%
Track how Tonix Pharmaceuticals Holding Corp. P/E has moved over time to understand its valuation trends.
Tonix Pharmaceuticals Holding Corp. in the last 5 years
Lowest (0.00x)
September 17, 2025
Industry (-3.93x)
September 17, 2025
Today (0.01x)
September 17, 2025
Highest (-0.64x)
March 31, 2025
Today’s Price to Earnings Ratio: 0.01x
Compare market cap, revenue, PE, and other key metrics of Tonix Pharmaceuticals Holding Corp. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $237.7M | -100% | 0.01 | 0.00% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Tonix Pharmaceuticals Holding Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Tonix Pharmaceuticals Holding Corp. investment value today
Current value as on today
₹1,98,476
Returns
₹98,476
(+98.48%)
Returns from Tonix Pharmaceuticals Holding Corp. Stock
₹93,878 (+93.88%)
Dollar Returns*
₹4,598 (+4.6%)
Based on 8 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Tonix Pharmaceuticals Holding Corp.. Average target price of $61.67
Get share price movements and forecasts by analysts on Tonix Pharmaceuticals Holding Corp..
What analysts predicted
53.79%UPSIDE
Target Price
$61.67
Current Price
$28.5
Analyzed by
8 Analysts
Target
$61.67
Tonix Pharmaceuticals Holding Corp. target price $61.67, a slight upside of 53.79% compared to current price of $28.5. According to 8 analysts rating.
Investment in Tonix Pharmaceuticals Holding Corp. Shares on INDmoney has grown by 53.76% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:53.76% versus previous 30 day period
Search interest for Tonix Pharmaceuticals Holding Corp. Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:24% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, TNXP has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 216.3%
Price Dip
In the last 1 month, TNXP stock has moved down by -47.2%
Profit Down
Netprofit is down for the last 2 quarters, -16.82M → -28.27M (in $), with an average decrease of 68.0% per quarter
Revenue Fall
Revenue is down for the last 4 quarters, 2.82M → 1.99M (in $), with an average decrease of 10.7% per quarter
Organisation | Tonix Pharmaceuticals Holding Corp. |
Headquarters | 26 Main Street, Chatham, NJ, United States, 07928 |
Industry | Health Technology |
CEO | Dr. Seth Lederman M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Darryl Rideout Ph.D. | Executive Vice President of Experimental Chemistry |
Dr. Sina Bavari Ph.D. | Executive Vice President of Infectious Disease Research & Development |
Dr. Zeil Rosenberg M.D., M.P.H. | Executive Vice President of Medical |
Mr. Bradley Saenger CPA | CFO & Treasurer |
Dr. Gregory M. Sullivan M.D. | Chief Medical Officer & Secretary |
Ms. Siobhan Fogarty B.Sc., M.Sc. | Chief Technical Officer |
Mr. Thomas Englese M.B.A. | Executive Vice President of Commercial Operations |
Dr. Seth Lederman M.D. | Co-Founder, President, CEO & Chairman |
Mrs. Jessica Edgar Morris | Chief Operating Officer |
Mr. Joseph Hand Esq., J.D. | General Counsel & Executive VP of Operations |
Tonix Pharmaceuticals Holding Corp. share price today is $28.5 as on . Tonix Pharmaceuticals Holding Corp. share today touched a day high of $29.19 and a low of $26.89.
Tonix Pharmaceuticals Holding Corp. share touched a 52 week high of $130 on and a 52 week low of $6.76 on . Tonix Pharmaceuticals Holding Corp. stock price today i.e. is trending at $28.5,which is 78.08% down from its 52 week high and 321.60% up from its 52 week low.
Tonix Pharmaceuticals Holding Corp. market capitalisation is $0.00T as on .
Indian investors can start investing in Tonix Pharmaceuticals Holding Corp. (TNXP) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Tonix Pharmaceuticals Holding Corp. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Tonix Pharmaceuticals Holding Corp. share’s latest price of $28.5 as on September 17, 2025 at 10:40 pm IST, you will get 0.3509 shares of Tonix Pharmaceuticals Holding Corp.. Learn more about
fractional shares .
Tonix Pharmaceuticals Holding Corp. stock has given -100% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?